| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Leukemia | |||||
| Lymphoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia, B-Cell | |||||
| Leukemia, Lymphocytic, Chronic, B-Cell | |||||
| Leukemia, Lymphoid | |||||
| Waldenstrom Macroglobulinemia | |||||
| 3 | More general conditions related to this trial | ||||
| Blood Protein Disorders | |||||
| Cardiovascular Diseases | |||||
| Hematologic Diseases | |||||
| Hemorrhagic Disorders | |||||
| Hemostatic Disorders | |||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Plasma Cell | |||||
| Paraproteinemias | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| apolizumab | |||||
| rituximab | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| NCI - Center for Cancer Research-Medical Oncology | |||||
| National Cancer Institute (NCI) | |||||
|
